Anne Wojcicki, the CEO of pioneering genetic testing company 23andMe, is open again to a third-party takeover of the company.

A Wilmore woman made quite the discovery after receiving results from a DNA kit, one that would lead to a shocking diagnosis.

Me is considering a sale of the company as it weighs up strategic options, capping a torrid year for the genetic testing ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...

Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic ...

By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...

The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.